Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Neurol. 2023 Oct;22(10):890-899. doi: 10.1016/S1474-4422(23)00285-5.
Lancet Neurol. 2023.
PMID: 37739572
Clinical Trial.
Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy.
Zambon AA, Ayyar Gupta V, Ridout D, Manzur AY, Baranello G, Trucco F, Muntoni F; UK Northstar Clinical Network.
Zambon AA, et al.
Dev Med Child Neurol. 2022 Aug;64(8):979-988. doi: 10.1111/dmcn.15176. Epub 2022 Feb 14.
Dev Med Child Neurol. 2022.
PMID: 35385138
Free PMC article.
Item in Clipboard
Cite
Cite